Jorge Useche
About Jorge Useche
Jorge Useche serves as the R&D Director at Clever Leaves in Bogotá D.C., Colombia, a position he has held since 2019. He has a background in pharmaceutical chemistry and business innovation, with degrees from Universidad Nacional de Colombia and Universidad Externado de Colombia.
Work at Clever Leaves
Jorge Useche serves as the Director de Investigación y Desarrollo (R&D Director) at Clever Leaves, a position he has held since 2019. He is based in Bogotá D.C., Colombia. In this role, he oversees research and development initiatives aimed at advancing the company's product offerings and innovation strategies. His leadership contributes to Clever Leaves' commitment to quality and compliance in the cannabis industry.
Education and Expertise
Jorge Useche completed his undergraduate studies at Universidad Nacional de Colombia, earning a degree in Químico Farmacéutico from 1994 to 2001. He furthered his education at Universidad Externado de Colombia, where he studied Desarrollo de Nuevos Negocios y gestión de procesos de Innovación, achieving a specialization in Innovación y Desarrollo de Negocios from 2012 to 2013. His educational background equips him with a strong foundation in pharmaceutical sciences and business innovation.
Background
Before joining Clever Leaves, Jorge Useche worked at Laboratorios La Santé as Gerente de Investigación y Desarrollo from 2005 to 2019. In this role, he was responsible for managing research and development projects, contributing to the company's growth and product development. His extensive experience in the pharmaceutical sector spans over two decades, focusing on innovation and development.
Professional Experience
Jorge Useche has significant experience in the pharmaceutical industry, particularly in research and development roles. His tenure at Laboratorios La Santé lasted 14 years, where he led various initiatives in R&D. His current position at Clever Leaves further demonstrates his expertise in driving innovation and managing complex projects within the pharmaceutical landscape.